Identification and Characterization of Families with Aggregation of Lung Cancer

Japanese Journal of Clinical Oncology

Volumn 28, Issue 3, 1998, Pages 192-195

  Tomizawa, Yoshio ^a,b   Adachi, Jun Ichi ^a   Kohno, Takashi ^a   Yamaguchi, Naohito ^a   Saito, Ryusei ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Cancer family syndrome; Genetic susceptibility; Hereditary non polyposis colorectal cancer; Li Fraumeni syndrome; Lung cancer

Indexed keywords

ARTICLE; COLORECTAL TUMOR; DISEASE PREDISPOSITION; FAMILIAL CANCER; FAMILY HEALTH; FEMALE; GENETICS; HUMAN; LUNG TUMOR; MALE; MULTIGENE FAMILY; MUTATION; RETINA TUMOR; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISEASE SUSCEPTIBILITY; FAMILY HEALTH; FEMALE; GENES, P53; GENES, RETINOBLASTOMA; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; LUNG NEOPLASMS; MALE; MULTIGENE FAMILY; NEOPLASTIC SYNDROMES, HEREDITARY; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 0032015545     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.3.192     Document Type: Article

References (31)

1. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312.
2. Sellers TA, Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE. Rothschild H. Increased familial risk for non-lung cancer among relatives of lung cancer patients. Am J Epidemiol 1987;126:237-46.
3. Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76:217-22.
4. McDuffie HH. Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 1991;44:69-76.
5. Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1986;134:466-70.
6. Brisman R, Baker RR, Elkins R, Hartmann WH. Carcinoma of lung in four siblings. Cancer 1967;20:2048-53.
7. Joishy SK, Cooper RA, Rowley PT. Alveolar cell carcinoma in identical twins. Ann Intern Med 1977;87:447-50.
8. Beaumont F, Jansen HM, Elema JD, Ten Kate LP, Sluiter HJ. Simultaneous occurrence of pulmonary interstitial fibrosis and alveolar cell carcinoma in one family. Thorax 1981;36:252-8.
9. Malkin D, Li FP, Strong LC, Fraument JF, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990;250:1233-8.
10. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:747-9.
11. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529-54.
12. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994;8:15-21.
13. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
14. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T. Loss of heterozygosity on chromosomes 3, 13 and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 1987;84:9252-6.
15. Yokota J, Akiyama T, Fung YKT, Benedict WF, Namba Y, Hanaoka M, et al. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogens 1988;3:471-5.
16. Shimizu E, Coxon A, Otterson GA, Steinberg SM, Kratzke RA, Kim YW, et al. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma and mesothelioma. Oncogene 1994;9:2441-8.
17. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994;9:3375-8.
18. Bronner CE, Baker SM, Mirrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
19. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
20. Adachi J, Shiseki M, Okazaki T, Ishimaru G, Noguchi M, Hirohashi S, et al. Microsatellite instability in primary and metastatic lung carcinomas. Genes Chromosome Cancer 1995;14:301-6
21. Ryberg D, Lindstedt BA, Zienolddiny S, Haugen A. A hereditary genetic marker closely associated with microsatellite instability in lung cancer. Cancer Res 1995;55:3996-9.
22. Vasen HFA, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
23. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review Gastroenterology 1993;104:1535-49.
24. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 1995;159:113-21.
25. Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 1996;87:18-24.
26. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalamen A, Pelkonen O, Vainio H. PCR-based CYP2D6 genotyping for Finnish lung cancer patients. Pharmacogenetics 1993;3;19-27.
27. Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe T, et al. Restriction fragment length polymorphism of human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 1994;4:58-63.
28. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14:1479-81.
29. Sellers TA, Bailey-Wilson JE, Elstone RC, Wilson AF, Elstone GZ, Ooi WL, et al Evidence for Menderian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 1990;82:1272-9.
30. Sugimura H, Watanabe S, Tsugane S, Morinaga S, Yoneyama T. Case-control study on histologically determined multiple primary lung cancer. J Natl Cancer Inst 1987;79:435-41.
31. Braun MM, Caporaso NE, Page WF, Hoover RN. Genetic component of lung cancer: cohort study of twins. Lancet 1994;344:440-3.